Setagaya, Japan Related Funds
| Fund Name | Location |
| Alwin Capital | Beijing, Beijing, China |
| Attestor Capital LLP | England, London, United Kingdom |
| China Yinhong | - |
| CKA Capital Ltd | England, London, United Kingdom |
| Dongyuan Huixin Equity Investment Fund Management | China, Shanghai |
| Dynamic Balance Capital | China, Jiangsu, Nanjing |
| EPOS | Capital Region of Denmark, Denmark, Hovedstaden |
| FSD Africa | Kenya, Nairobi, Nairobi Area |
| FueTrek | Japan, Osaka, Osaka Prefecture |
| FUNKE Digital | Berlin, Berlin, Germany |
| H. C. Wainwright & Co. | New York, New York, United States |
| Medica Venture Partners | Israel, Tel Aviv, Tel Aviv District |
| Primal Capital | Chiyoda, Japan |
| Quan Technology Fund | Geneva, Geneve, Switzerland |
| Risk Management Solutions | California, Newark, United States |
| Shanghai Chuangban Investment Management | China, Shanghai |
| Sopartec | - |
| Speedshield | - |
| Wanxiang Healthcare Investments | Elgin, Illinois, United States |
| ZG Ventures | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PetMedix | $36M | 08 Sep 2021 | Cambridge, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PetMedix | $36M | 08 Sep 2021 | Cambridge, England, United Kingdom |
